Inmunología y Genética Aplicada, S.A. (INGE) is a highly specialised Spanish Biotechnology company based in Madrid.
INGE was founded in 1981 with the aim of researching, developing and manufacturing diagnostic kits with a broad range of applications in Veterinary Diagnostics and Food Safety. Since February 2018, the company belongs to Eurofins Technologies, a world leader in food, environment and biopharmaceutical products testing
Inmunología y Genética Aplicada, S.A. (INGE) is a highly specialised Spanish Biotechnology company based in Madrid.
INGE was founded in 1981 with the aim of researching, developing and manufacturing diagnostic kits with a broad range of applications in Veterinary Diagnostics and Food Safety. Since February 2018, the company belongs to Eurofins Technologies, a world leader in food, environment and biopharmaceutical products testing.
INGE has a multidisciplinary team of 55 employees, formed by biologists, chemists, pharmacists, veterinarians, laboratory technicians, business economists, salespeople…. Over the last 38 years, INGE has put a very strong focus on research and innovation and has a relevant experience on recombinant proteins and monoclonal antibodies development and production, which are used for the development of diagnostic test. Nowadays, INGE provides its customers with a wide range of ELISA, LFD and PCR assays to detect viral and bacterial pathologies in both farm and companion animals and has developed a new diagnostic line focused on food safety. Moreover, the company has participated in several research projects on human health, such as identification of new carcinogenic markers (lung, ovarian, colon and melanoma) and diagnosis of respiratory viral infections in the elderly.
INGE has a vast experience in the participation, coordination and management of National and European research programs. Based on its research, INGE has registered 109 patents in 15 different families, has published over 130 scientific papers and produces and commercializes 180 diagnostic products, covering 54 pathologies in 9 animal species and food safety (ingenasa.eurofins-technologies.com).

ROLE IN PROJECT

INGE will be responsible for the production of reagents (antibodies (Ab) and target llergens) as well as for the production of new antibodies and/or improvement of the existing ones by production of smaller molecules such as Fab’2 or recombinant antibodies, leading WP4. In addition, INGE will lead WP6 dedicated to the demonstration, coordinating among others the demonstration of SaPher bio-sensing test platform at in-house laboratories (Eurofins Technologies). INGE will be also responsible for the dissemination and communication plan, coordinating WP7. The role of INGE is key for the successful industrialization of SaPher, as it is a company that already makes and sells robot for the agricultural sector.

PHOTO (S)